Partner Content Partner Content Managing and Tracking Cross-functional KOL Collaborations How to manage and track KOLs
Partner Content Partner Content Overwhelmed with KOL Data how to navigate through KOL insights & management
Partner Content Partner Content Key Questions To Boost Your KOL Management – Part 8/8: Measu... KOL mgmt- measuring impact
Partner Content Partner Content Key Questions To Boost Your KOL Management – Part 7/8: Inter... KOL Management- Internal process
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
